Posts Tagged: Transitional Medicine

New Study Published in Molecular Medicine Reports that Novel Agent Decreases Neuropathic Pain in Patients with Type 2 Diabetes


Promising profile of disease modification and pain reduction leads to proof of concept trials Manhasset, NY – Molecular Medicine, a peer-reviewed biomedical journal published by the Feinstein Institute Press, published the results of a new study reporting clinically significant pain reduction in type 2 diabetic patients. In an exploratory study conducted by Araim Pharmaceuticals, a biotech… read more

posted in: Press Releases tags: